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List of abbreviations 
5-HT  serotonine 
ADR  adrenalin 
DA  dopamine 
HA  histamine 
i.c.v.  intracerebroventricular 
i.p.  intraperitoneal 
ISH  in situ hybridization 
LHA  lateral hypothalamus 
NH  neurohypophysis 
NADR  noradrenalin 
OT  oxytocin 
OX1R  orexin-1 receptor 
OX2R  orexin-2 receptor 
PCR   polymerase chain reaction 
PVN  nucleus paraventricularis 
RIA  radioimmunoassay 
SON  nucleus supraopticus 
VP   vasopressin 
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Introduction 
 
The neuropeptides expressed by a specific population of neurons in the LHA, are called 
orexins (earlier: hypocretins). Orexin-A contains 33 amino-acids with two intramolecular 
disulfide bonds, while orexin-B is a linear 28-residue peptide. Orexin-A and orexin-B bind 
and activate the G-protein-coupled receptors, OX1R and OX2R, which are generated from 
two separate genes. Orexin-A has a 10-fold higher affinity to OX1R than orexin-B.  
SB 408124 is a selective antagonist for OX1R.  
The orexins act as neurotransmitters in the regulation of the hormonal system and the 
maintenance of the energy balance via the food intake. Other observation have indicated 
that, either stimulation of LHA or following i.c.v. administration of orexins increases water 
intake and plays a physiological role in the regulation of drinking behaviour. Orexin-
positive fibres and orexin receptor mRNAs coexist with NH hormones in the PVN and 
SON, such as VP and OT.  
 
VP, this 9-amino-acid hormone is synthesized in the hypothalamic SON and PVN neurons 
and transported in packed neurosecretory granules into the NH by axons. Then VP is 
secreted into the circulation through the local portal veins. In contrast with the opinion that 
NH is only a storage site of the VP, it has been showed that dispersed cell cultures of 
isolated NH obtained from adult rats are able to synthesize and release VP. These 
observations are based on the immunological and spectrometrical identification of VP 
from the cell cultures. It has been also proved with ISH and PCR methods that the 
pituicytes of NH could be the sites of VP mRNS expression.  
 
The monoaminerg compounds of the brain, which are localized in the magnocellular 
portion of the hypothalamus and which are secreted from nerve terminals into the 
posterior lobe of the hypophysis, play an important role in the regulation of VP secretion. 
These neuroactive compounds (HA, DA, ADR, NADR, 5-HT) enhance the VP secretion 
from pituicytes in isolated NH cell cultures in vitro and in rats in vivo. It is general that 
hyperosmotic stimulation, such as hyperosmotic NaCl i.p injection causes increased VP 
level in blood.  
 
It appeared worthwhile to investigate whether the orexins exert their polydipsic and 
polyuric effects through alterations in VP secretion.  
 
3 
 
Aims 
 
The anatomical localization and physiological roles of the above-mentioned 
neurotransmitters suggest that they are in functional connections with each other. We 
therefore designed our experiments to investigate the interrelation of VP secretion and 
water metabolism with the orexins in vitro and in vivo.  
 
The following questions were examined by in vivo studies: 
 
1. Are there any differences between the effects of either ic.v. administered orexin-A 
or orexin-B on the food or water intake in rats? 
2. How can orexin neuropeptide modify the increased VP secretion in rats after 
osmotic stimulus (i.p. administration of 2.5% NaCl)? 
3. How can orexin neuropeptide influence the non-osmotically-induced (i.p. 
administration of HA) VP level increase? 
4. Can the OX1R antagonist prevent the orexin-A-induced VP secretion changes in 
rats? 
 
The following questions were examined by in vitro studies: 
 
1. In isolated rat NH cell cultures is there any direct effect of the orexins on the VP 
release? 
2. Do these two neuropeptides, orexin-A or orexin-B, modify the monoaminerg-
induced VP release changes in the supernatant media of NH cell cultures? 
3. How can orexin-A or orexin-B modify the VP release changes induced in the 
supernatant media of isolated NH cell cultures after aspecific osmotic stimulus (K+ 
treatment)? 
4. Can the OX1R antagonist prevent the monoaminerg-induced VP secretion changes 
of the supernatant media of isolated NH cell cultures? 
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Materials and methods 
In vivo experiments 
180-230 g male Wistar were used. The rats were randomized before the experiments and 
housed for 1 week, and cannulated (into the right lateral ventricle) under ether 
anaesthesia 7 days before the studies.  
Water consumption and food intake were measured for 6 and 4 h following i.c.v. 
injections.  
Blood was obtained following decapitation 30 min after orexin administration and 15 min 
after hyperosmotic or HA stimulation. The plasma VP level was measured by RIA.  
Statistical analysis was performed by using the Turkey-Kramer multiple comparison test. 
The following compounds were used during the experiments: 
1. Orexin-A or orexin-B (i.c.v. 10-30-90 μg/10 μl/animal) 
2. 2.5% NaCl solution (i.p. 1ml/100g animal, 15 min after orexin administration) 
3. HA (i.p. 1 mg/100g animal; 15 min after orexin administration) 
4. OX1R antagonist: SB408124 (N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N′-[4-
(dimethylamino)phenyl]urea) (i.c.v. 30 μg/10μl/animal, simultaneously 
administered with the orexin) 
The animal care and research protocols were in accordance with the guidelines of our 
university and had been approved in advance by the appropriate ethical committee. 
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In vitro experiments 
The pituitary of male Wistar rats weighing 180-230 g was removed under sterile conditions 
immediately after decapitation under anaesthesia.  
The posterior lobe was carefully separated and digested enzimatically (trypsin, 
collagenase, DN-ase I-II). The viability was 99-100%, and the cell count was determinate 
to be 2x106/dish. The cell cultures were maintained in 24-well plastic plates with collagen 
at 37 °C and humified atmosphere of 5% CO2 in air.  
The VP level of the supernatant media was measured by RIA on days 13 or 14, the 
hormone content of the medium had become constant by this time. 
For the study of the interactions of the orexins and the monoaminergic system, the 
compounds were administered in 60 min differences.  
A modified Lowry method was used for the determination of total protein content. 
Statistical analysis of VP concentrations was performed with the Kruskal-Wallis test. 
The following compounds were used during the experiments: 
1. orexin-A or orexin-B (10-10-10-4 M)  
2. HA, DA, ADR, NADR, K+ (10-6 M) 
3. SB408124 (10-6 M) 
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Results  
 
In vivo experiments 
 
Effects of orexins on water and food intake: 
 
Our observations confirm that feeding behaviour can be stimulated by the orexins: the 
total food consumption during 1 h after orexin administration increased in a dose-
dependent manner. One aim of our study was to investigate whether orexins can 
modulate drinking behaviour and thereby influence VP secretion. Orexin-A administered 
i.c.v. resulted in a significant increase in water consumption 4-6 h after the injection at all 
concentrations, but the elevation proved much higher for the 30 μg/10 μl dose. To reveal 
the manner in which the orexins possibly influence drinking behaviour, we carried out 
examinations with a specific OX1R antagonist. SB 408124 in the same concentration as 
orexin-A considerably reduced this increase, but the water intake still remained 
significantly higher as compared with the controls.  
 
Effects of orexin-A on plasma VP level: 
 
Following the i.c.v. administration of orexin-A or SB 408124 in different concentrations 
(10-30-90 μg/10 μl, n= 8-10), the plasma VP level did not change relative to the untreated 
controls. Hyperosmotic stimulation with 2.5% NaCl solution injected i.p. resulted in a high 
increase in plasma VP concentration; this was reduced by previous orexin administration. 
The highest effect was observed for the 30 μg/10 μl orexin dose, but the VP level was not 
as low as that of the control. I.p. HA injection significantly increased the plasma VP 
concentration, to a much higher level than that following the hyperosmotic stimulus. 
Orexin administered i.c.v. before the HA injection in each case reduced the HA-induced 
increase in plasma VP concentration, but the VP levels still remained above those of the 
vehicle controls. At the most effective dosage (30 μg/10 μl), treatment with the specific 
OX1R antagonist SB 408124 together with orexin-A after HA or hyperosmotic saline 
injection prevented the reduction in VP level increase.  
 
In vitro experiments: 
 
Following the administration of orexin-A or orexin-B, significant changes in the basal VP 
concentration were not observed in the cell culture medium. 
E, NE or DA administration increased VP secretion in a similar manner. Preincubation with 
orexin-A or orexin-B reduced the E or NE-induced increases in VP level. DA 
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administration proved to be ineffective in this respect. Following E, NE or DA treatment, 
orexin-A or orexin-B did not induce changes in VP release. Preincubation with orexin-A or 
orexin-B reduced the HA or 5-HT-induced VP level increases, but the VP concentrations 
of the supernatant media remained above the control level. Substantial differences in 
decreasing effect were not observed between orexin-A or orexin-B. Neither orexin-A nor 
orexin-B induced changes in VP release following monoaminergic treatment. Orexins had 
no influence on the VP level increase induced by K+, which causes non-specific hormone 
secretion. 
 
Conclusions 
 
1. Orexin-A or orexin-B increased the water consumption. The 30 µg/ 10 µl dosage 
resulted the highest effect. After orexin-A administration, the polydipsia was more 
pronounced. The OX1R antagonist decreased the polydipsia significantly.  
2. Histamine or hyperosmotic VP release enhancement was reduced by i.c.v. orexin 
administration. This inhibition was not observed following OX1R antagonist 
administration.  
3. Our results suggest that the effect of orexin on the water consumption or blockade 
of the histamine and osmotic-induced VP level increase is mediated by the OX1R.  
4. The changes in VP secretion of isolated rat NH cell cultures induced by the 
monoaminergic system can be directly influenced by the orexin system.  
5. The interactions between the monoaminergic and orexin systems regarding VP 
secretion occur at the level of the posterior pituitary. 
 
Summary 
 
Our results show that the orexins stimulate food intake and water consumption, acting 
through the orexin receptors, and resulted polydipsia and polyuria. We have now 
demonstrated that the orexins are physiologically involved in the regulation of VP release: 
although the orexins do not cause a VP level enhancement themselves, they can clearly 
reduce the osmotically induced elevation of the plasma VP concentration both in vitro and 
in vivo, and the reduction is prevented by the OX1R antagonist SB 408124 in the case of 
orexin-A treatment, which furnishes further evidence of the receptor-mediated pathway.  
Via the results of in vitro studies we demonstrated that the interactions between the 
monoaminerg and orexin system occur both at the levels of hypothalamus and the 
posterior pituitary. 
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